THYROID EYE DISEASE

This study tested a drug called aflibercept, given as an injection around the eye, to see if it is safe for people with active thyroid eye disease. Eleven adults with mild to moderate symptoms received three injections over several weeks. The main goal was to check for side effec…

This study tested an investigational drug called veligrotug in 188 people with chronic thyroid eye disease, a condition that causes eye bulging and discomfort. The goal was to see if the drug could safely reduce eye bulging compared to a placebo. The drug works by blocking a spec…

This study tested a drug called batoclimab in 114 adults with active thyroid eye disease, a condition that causes eye bulging and inflammation. Participants received weekly injections of batoclimab or a placebo for 24 weeks. The main goal was to see if batoclimab could reduce eye…

This study looked at how well the drug teprotumumab works for thyroid eye disease, a condition that can cause bulging eyes. It involved 5 people in China who received the drug. The main goal was to see if their eye bulging improved by at least 2 millimeters after treatment.

This study tested a new drug called LASN01 in 41 adults with moderate-to-severe thyroid eye disease, a condition that causes eye bulging and discomfort. The drug aims to reduce eye bulging and inflammation by blocking a specific receptor. Participants received either LASN01 or a …

This study tested an investigational drug called VRDN-001 in 143 adults with thyroid eye disease who did not respond to their initial treatment in earlier studies. The drug aims to reduce eye swelling and bulging by blocking a specific receptor. The goal was to see if it could sa…

This study tested a drug called VRDN-001 in 231 people with thyroid eye disease, a condition that causes eye swelling and bulging. The drug works by blocking a receptor linked to inflammation. The main goal was to check safety and how well people tolerate the treatment.

This study looked at how safe and tolerable different lengths of treatment with teprotumumab are for adults with Thyroid Eye Disease (TED), a condition that can cause bulging eyes and discomfort. About 313 participants received the drug for varying durations to see if shorter or …

This study tested a new medicine called IBI311 for people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. About 38 adults with either active or inactive disease received different doses of the drug. The main goals were to see if it safely reduces…

This study tested a drug called batoclimab for people with active thyroid eye disease, a condition that causes eye bulging, redness, and swelling. 86 adults with moderate to severe symptoms received weekly injections of either batoclimab or a placebo for 24 weeks. The main goal w…